TY - JOUR T1 - Potentiation of Sulfonylurea Action by an EPAC-selective cAMP Analog in INS-1 Cells: Comparison of Tolbutamide and Gliclazide and a Potential Role for EPAC Activation of a 2-APB-sensitive Ca<sup>2+</sup> Influx JF - Molecular Pharmacology JO - Mol Pharmacol SP - 191 LP - 205 DO - 10.1124/mol.112.081943 VL - 83 IS - 1 AU - Rachel E. Jarrard AU - Yuchen Wang AU - Amy E. Salyer AU - Evan P.S. Pratt AU - Ian M. Soderling AU - Marcy L. Guerra AU - Allison M. Lange AU - Hilary J. Broderick AU - Gregory H. Hockerman Y1 - 2013/01/01 UR - http://molpharm.aspetjournals.org/content/83/1/191.abstract N2 - Tolbutamide and gliclazide block the KATP channel Kir6.2/Sur1, causing membrane depolarization and stimulating insulin secretion in pancreatic beta cells. We examined the ability of the EPAC-selective cAMP analog 8-pCPT-2′-O-Me-cAMP-AM to potentiate the action of these drugs and the mechanism that might account for it. Insulin secretion stimulated by both 200 μM tolbutamide and 20 μM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 μM) or the L-type Ca2+ channel blocker nicardipine (2 μM) and was potentiated by 8-pCPT-2′-O-Me-cAMP-AM at concentrations ≥2 μM in INS-1 cells. Ca2+ transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2′-O-Me-cAMP-AM at 5 μM but not 1 μM. Both tolbutamide and gliclazide stimulated phospholipase C activity; however, only gliclazide did so independently of its activity at KATP channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2′-O-Me-cAMP-AM alone (5 μM) did not stimulate insulin secretion, but did increase intracellular Ca2+ concentration significantly, and this activity was inhibited by 25 μM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca2+. 8-pCPT-2′-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 μM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 μM). Our data demonstrate that the actions of both tolbutamide and gliclazide are strongly potentiated by 8-pCPT-2′-O-Me-cAMP-AM, that gliclazide can stimulate phospholipase C activity via a partially pertussis toxin-sensitive mechanism, and that 8-pCPT-2′-O-Me-cAMP-AM potentiation of tolbutamide action may involve activation of a 2-APB-sensitive Ca2+ influx. ER -